Tratamiento quirúrgico de estenosis duodenal secundaria a enfermedad de Crohn

Chóliz Ezquerro, Jorge; Aparicio López, Daniel; García López, Santiago; Hörndler Argárate, Carlos; Serradilla Martín, Mario.
Rev. esp. enferm. dig ; 115(12): 733-734, Dic. 2023. ilus
Artículo en Inglés, Español | IBECS (España) | ID: ibc-228723

Documentos relacionados

  1. Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
  2. Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group.
  3. Duodenal stenosis surgical treatment in Crohn's disease.
  4. A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
  5. Pyoderma gangrenosum and impact on quality of life: A narrative review.
  6. Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.
  7. Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study.
  8. Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases.
  9. Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
  10. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.